Management of active and established corneal neovascularisation to prevent visual impairment - Strategies for management of corneal noevascularisation

niversity of Nottingham0 个研究点目标入组 40 人开始时间: 2019年7月9日最近更新: 2019年12月16日

试验速览

暂无简介。

•Patients with all the below criteria:
•-Patients over the age of 18
•-Able to give informed consent
•-Use of effective contraception in females of childbearing age
•-With corneal neovascularisation non responsive or not suitable for conventional steroid therapY
•Are the trial subjects under 18? no
•Number of subjects for this age range: 0
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 20
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 20

•-Patients under 18 years of age
•-Patients unable or refusing to provide informed consent
•-Patients who are needle phobic
•-Pregnant women or women aiming for conception and breast feeding women.
•-Patients with hypersensitivity to the active substance or to any of the excipients
•-Patients with active or suspected ocular or periocular infections.
•-Patients with active severe intraocular inflammation.
•-Patients with raised intraocular pressure or on glaucoma medication

发起方

niversity of Nottingham